Skip to main content
. 2023 Apr 27;14:1156621. doi: 10.3389/fphar.2023.1156621

FIGURE 2.

FIGURE 2

Change in (A) FEV1 and (B) sweat chloride at baseline, on full standard dose, and reduced dose of ETI therapy.